0
Your cart

Your cart is empty

Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Neurosciences

Buy Now

Hepatic Encephalopathy - Pathophysiology and Treatment (Paperback, Softcover reprint of the original 1st ed. 1989) Loot Price: R6,632
Discovery Miles 66 320
Hepatic Encephalopathy - Pathophysiology and Treatment (Paperback, Softcover reprint of the original 1st ed. 1989): Roger F....

Hepatic Encephalopathy - Pathophysiology and Treatment (Paperback, Softcover reprint of the original 1st ed. 1989)

Roger F. Butterworth, Gilles Pomier Layrargues

Series: Experimental Biology and Medicine, 22

 (sign in to rate)
Loot Price R6,632 Discovery Miles 66 320 | Repayment Terms: R622 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Hepatic Encephalopathy (HE) is a neuropsychiatric disorder resul t- ing from liver failure. HE may be associated with fulminant (acute) hepatic failure or chronic liver disease with portal-systemic shunting. The latter condition is characterized neuropathologically by astro- cytic rather than neuronal changes (Alzheimer Type II astrocytosis). The former is frequently accompanied by cerebral edema. Several hypotheses have been proposed to explain the pathogene- sis of HE. These include: 1. A toxic action of a substance (or substances) such as ammonia on brain function 2. A deficit of cerebral energy metabolism 3. Neurotransmitter changes, and, more recently 4. The role of "endogenous benzodiazepines. " This volume summarizes the results of a symposium held in Val David, Quebec from October 3D-November I, 1988, that was devoted to an evaluation of the evidence for and against the various hypothe- ses of HE. Data from studies in patients, in experimental (animal) models of HE, and in cultured cell preparations were discussed. In addition, a review of available approaches to the treatment and man- agement of HE was included. The therapeutic use of lactulose, anti- biotics, dietary treatment, and branched-chain amino acid treatments were included, as well as the results of preliminary studies of the therapeutic use of the benzodiazepine antagonist, flumazenil. Roger F. Butterworth, PhD Gilles Pomier Layrargues, MD v Acknowledgments The symposium was made possible by the generous financial assistance of: Hoffman-La Roche Ltd.

General

Imprint: HumanaPress
Country of origin: United States
Series: Experimental Biology and Medicine, 22
Release date: September 2011
First published: 1989
Authors: Roger F. Butterworth • Gilles Pomier Layrargues
Dimensions: 235 x 155 x 33mm (L x W x T)
Format: Paperback
Pages: 622
Edition: Softcover reprint of the original 1st ed. 1989
ISBN-13: 978-1-4612-8851-0
Categories: Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Neurosciences
LSN: 1-4612-8851-7
Barcode: 9781461288510

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners